Slow decline of plasma drug and prolactin levels after discontinuation of chronic treatment with depot neuroleptics.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  The Lancet

• Publication date

  1981-05-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(81)92334-5PMID 6112518
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Kinetics of fluphenazine after fluphenazine dihydrochloride, enanthate and decanoate administration to man.

  1979cited by this paper
• Radioimmunoassay for fluphenazine in human plasma.

  1978cited by this paper

• Antipsychotic-induced hyperprolactinemia: synthesis of world-wide guidelines and integrated recommendations for assessment, management and future research

  2017cites this paper
• Interventions for antipsychotic‐induced amenorrhoea

  2016cites this paper
• Antipsikotiklere Bağli Hiperprolaktinemi Antipsychotic-induced Hyperprolactinemia

  2015cites this paper
• [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].

  2014cites this paper
• Pharmacokinetics of Long Acting First Generation Antipsychotic Fluphenazine: A case report and review of the literature Authors: Tara L. Purvis, PharmD

  2014cites this paper
• Hyperprolactinémies induites par les antipsychotiques : physiopathologie, clinique et surveillance

  2014cites this paper
• Modern Psychopharmacology and Psychiatric Treatment

  2013cites this paper
• Case Based Clinical Pearls: A schizophrenic case study

  2012cites this paper
• The Potential Role of Long-Acting Injectable Antipsychotics in People With Schizophrenia and Comorbid Substance Use

  2012cites this paper
• Antipsychotic-Induced Hyperprolactinaemia

  2012cites this paper
• Oral versus Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Special Populations at Risk for Treatment Nonadherence: A Systematic Review

  2012influential citation
• Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia

  2012cites this paper
• Risk of osteoporosis and fracture incidence in patients on antipsychotic medication

  2011cites this paper
• Effect of bromocriptine on antipsychotic drug‐induced hyperprolactinemia: Eight‐week randomized, single‐blind, placebo‐controlled, multicenter study

  2010cites this paper
• 34 Psychopharmacology and Other Somatic Therapies

  2008cites this paper
• Clinical questions and uncertainty — prolactin measurement in patients with schizophrenia and bipolar disorder

  2008influential citation
• Clinical Psychopharmacology and Other Somatic Therapies

  2008cites this paper
• Accuracy and intensity of posed emotional expressions in unmedicated schizophrenia patients: vocal and facial channels.

  2007cites this paper
• Drug-induced hyperprolactinemia.

  2006cites this paper
• Amphetamine response and relapse risk after depot neuroleptic discontinuation

  2004cites this paper
• Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration

  2004cites this paper
• A depot neuroleptic withdrawal study neurological effects

  2004cites this paper
• Platelet serotonin and plasma prolactin and cortisol in healthy, depressed and schizophrenic women.

  2004cites this paper
• Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity and consequences

  2003cites this paper
• Selective literature review Selective literature review

  2003cites this paper
• Antipsychotic-induced hyperprolactinaemia Antipsychotic-induced hyperprolactinaemia in women: pathophysiology, severity in women: pathophysiology, severity

  2003cites this paper
• Antipsychotic-induced hyperprolactinaemia in women : pathophysiology , severity and consequences Selective literature review

  2003cites this paper
• Prolactin and schizophrenia: clinical consequences of hyperprolactinaemia.

  2002cites this paper
• Antipsychotic induced hyperprolactinaemia: a series of illustrative case reports

  2001cites this paper
• The determination fluphenazine of the steady-state pharmacokinetic profile of decanoate by gas chromatography / mass spectrometry detection

  2001cites this paper
• Non-aqueous solutions and suspensions as sustained-release injectable formulations

  2000cites this paper
• Optimising the Use of Depot Antipsychotics

  1996cites this paper
• Do schizophrenic patients show a disjunctive relationship among expressive, experiential, and psychophysiological components of emotion?

  1996cites this paper
• Neuroleptic withdrawal in schizophrenic patients.

  1995cites this paper
• Depot Neuroleptic Therapy: Clinical Considerations

  1995cites this paper
• Depot neuroleptic therapy: clinical considerations.

  1995cites this paper
• How does the psychiatric patient feel about depot treatment, compulsion or help?

  1995cites this paper
• A multimethod, multichannel assessment of affective flattening in schizophrenia.

  1994influential citation
• Reducing Dosage in Maintenance Treatment of Schizophrenia

  1993cites this paper
• Flat affect in schizophrenia does not reflect diminished subjective experience of emotion.

  1993cites this paper
• The determination of the steady-state pharmacokinetic profile of fluphenazine decanoate by gas chromatography/mass spectrometry detection.

  1992cites this paper
• of the steady-state pharmacokinetic profile of decanoate by gas chromatography/mass spectrometry detection

  1992cites this paper
• Depot neuroleptics: Involuntary castration?

  1992cites this paper
• Medication effects: Conceptual and methodological issues in schizophrenia research

  1992cites this paper
• Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress.

  1992cites this paper
• Lack of effect of electroconvulsive therapy on CSF peptide concentrations in schizophrenic patients

  1991cites this paper
• [Study of residual levels of delayed-action neuroleptics].

  1991cites this paper
• Neuroendocrine effects of psychotropic drugs.

  1991cites this paper
• Sweden: Neuroleptic Treatment Strategies and Practical Problems During Drugs Withdrawal

  1991cites this paper
• Persistent neuroleptic – related hypersonmia: two case reports

  1991cites this paper
• 2 Neuroendocrine effects of psychotropic drugs

  1991cites this paper
• Sight and Insight: Regional Cerebral Metabolic Activity in Schizophrenia Visualised by Positron Emission Tomography, and Competing Neurodevelopmental Perspectives

  1990cites this paper
• Können wir das Ansprechen auf die somatischen Therapien der Schizophrenie verbessern

  1988cites this paper
• Persistence of fluphenazine in plasma after decanoate withdrawal.

  1988cites this paper
• Depot Neuroleptic Medication and Serum Levels by Radioreceptor Assay: Prolactin Concentration, Electrocardiogram Abnormalities and Six-Month Outcome

  1987cites this paper
• Depot neuroleptic medication and serum levels by radioreceptor assay: prolactin concentration, electrocardiogram abnormalities and six-month outcome.

  1987cites this paper
• A comparative trial of haloperidol decanoate and fluphenazine decanoate in chronic schizophrenic patients.

  1986cites this paper
• Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.

  1986cites this paper
• Plasma fluphenazine concentrations in outpatients receiving fluphenazine decanoate (Modecate)

  1986cites this paper
• Depot fluphenazine and plasma prolactin.

  1985cites this paper
• Chronic schizophrenia.

  1985cites this paper
• Clinical Pharmacokinetics of the Depot Antipsychotics

  1985cites this paper
• Neuroleptics and Prolactin

  1984cites this paper
• Intervals between long acting neuroleptics: outcome and re-admission variables.

  1984cites this paper
• Correlation of fluphenazine plasma levels versus clinical response in patients: a pilot study.

  1983cites this paper
• Neuroleptika: Grundlagen und Therapie

  1983cites this paper
• Proceedings of the British Pharmacological Society. 5th-7th January, 1983. Abstracts.

  1983cites this paper
• Prolactin levels and effects of neuroleptics.

  1983cites this paper
• The effect of propranolol on CSF amine metabolites in psychiatric patients.

  1983cites this paper
• 15O positron emission tomographic scanning in predominantly never-treated acute schizophrenic patients.

  1983cites this paper
• The clearance of oily vehicles following intramuscular and subcutaneous injections in rabbits

  1983cites this paper
• Proceedings of the British Pharmacological Society 8th-10th September, 1982. Abstracts.

  1982cites this paper
• Long-acting injectable neuroleptics

  1982cites this paper
• Once Weekly Pimozide versus Fluphenazine Decanoate as Maintenance Therapy in Chronic Schizophrenia

  1982cites this paper
• Chapter 4 – Antischizophrenic drugs

  1982cites this paper
• Functional Heterogeneity of Multiple Dopamine Receptors during Six Months' Treatment with Distinct Classes of Neuroleptic Drugs

  1982cites this paper
• A depot neuroleptic withdrawal study

  1981cites this paper
• Neuroleptics and antipsychotic drugs

  1981cites this paper